Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TECAR and FES for Hand Function in Post-Stroke Spasticity

NCT: NCT07889921 · COMPLETED

NCT IDNCT07889921
StatusCOMPLETED
Start Date2026-06-20
Completion2026-08-20
SponsorOctober 6 University (OTHER)
First posted
Last updated

Brief Summary

Upper-limb spasticity and impaired hand function are experienced by up to 70% of stroke survivors, which significantly restricts their independence in fulfilling daily activities. This research aims to assess whether combining TECAR therapy with FES produces superior improvements in hand function compared to FES alone in stroke patients with upper-limb spasticity.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑